Mark F. Pyfer MD MS
Anterior Segment Related, Cataract Related, Refractive Surgery
Surgical Instructor, Ophthalmology, Wills Eye Hospital - Thomas Jefferson University
Join to view full profile
500 York RdSuite 102Jenkintown, PA 19046
Phone+1 215-885-6830
Fax+1 215-885-2433
Dr. Pyfer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Pyfer is an ophthalmologist based in Jenkintown, PA, with subspecialties in anterior segment, cataract, and refractive surgery. He completed his residency at Wills Eye Hospital in 1999 and has been an attending physician there since. He also serves as Vice President and Surgical Director at Northern Ophthalmic Associates. Dr. Pyfer is skilled and highly experienced in cataract, refractive and glaucoma surgery and has authored multiple publications in this specialty. He played a leading role in the GEMINI study on minimally invasive glaucoma treatment. His honors include leadership roles and certifications, such as President of the New York Intraocular Lens Implant Society and Fellow of the College of Physicians of Philadelphia.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1996 - 1999
Abington Memorial HospitalInternship, Internal Medicine, 1995 - 1996
Perelman School of Medicine at the University of PennsylvaniaClass of 1995
Certifications & Licensure
PA State Medical License 1996 - 2026
DE State Medical License 1998 - 2025
NJ State Medical License 2000 - 2005
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- President New York Intraocular Lens Implant Society, 2019-2021
- Fellow College of Physicians of Philadelphia, 2019
- CMS Meaningful Use Stage 2 Certification MDoffice, MDoffice LLC, 2012, 2014, 2016-2017
Clinical Trials
- Study of OMNI System in OAG (GEMINI) Start of enrollment: 2019 Mar 11
- Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis Start of enrollment: 2021 Apr 29
Publications & Presentations
PubMed
- Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System: A Subgroup Analysis from the American Academy of Ophthalmology IRISRegistry (Intelligent Rese...Mark F Pyfer, Christine Funke, Sameh Mosaed, Erin Zwick, Jennifer Toth
Clinical Ophthalmology. 2025-01-01 - 27 citationsCanaloplasty and Trabeculotomy Combined with Phacoemulsification for Glaucoma: 12-Month Results of the GEMINI Study.Mark J Gallardo, Mark F Pyfer, Steven D Vold, Steven R Sarkisian Jr, Anita Campbell
Clinical Ophthalmology. 2022-01-01 - 13 citationsSuppression of Diurnal (9AM-4PM) IOP Fluctuations with Minimally Invasive Glaucoma Surgery: An Analysis of Data from the Prospective, Multicenter, Single-Arm GEMINI St...Mark F. Pyfer, Mark J. Gallardo, Anita Campbell, Brian E. Flowers, Jaime E. Dickerson
Clinical Ophthalmology. 2021-09-24
Press Mentions
VIDEO: Femtosecond Laser OCT Biometry Improves IOL CalculationsJune 4th, 2019
This Summer, Don’t Forget Your SunglassesAugust 11th, 2017- Expert Discusses How Fireworks Aren’t the Only Dangers to Your EyesJuly 4th, 2017
Professional Memberships
- Fellow
- Member
- Member
- Member
- International Society of Refractive SurgeonsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
